More NewsRead More
Exalenz Bioscience Announces the Global Market Launch of the New BreathID® Hp for Detection and Management of H. pylori
July 15, 2013
Exalenz Bioscience Launches Pivotal Study of World’s First Breath-Based Test to Diagnose Clinically Significant Portal Hypertension
October 21, 2014
Exalenz Bioscience to Present at Upcoming Investor Conferences
September 29, 2014
Exalenz Bioscience Expands Its Breath Testing Technology into the Potential Billion Dollar Liver Diagnostic Market
May 21, 2014
Exalenz Granted US Patent for Liver Application of Company’s BreathID Platform Technology
August 21, 2013
Exalenz Bioscience Names Ted Foltyn New VP of Worldwide Marketing and Business Development
June 24, 2013
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here